Headlines

Marathon Stock Soars 12% In Monday Trading

(VIANEWS) – Marathon’s stock rose by 12.02% to EUR26.76 on Monday, continuing its upward trajectory. Additionally, the NASDAQ index gained 0.45%, reaching EUR16,062.988; marking four consecutive days of gains for Marathon. Marathon closed its previous trading session at EUR23.89 which was 23.67% lower than its 52-week high of EUR31.30. About Marathon Marathon Digital Holdings, Inc….

Read More

NASDAQ Composite Bullish Momentum With A 6% Jump In The Last 21 Sessions

(VIANEWS) – NASDAQ Composite (IXIC) has been up by 6.82% for the last 21 sessions. At 10:12 EST on Monday, 12 February, NASDAQ Composite (IXIC) is $15,990.42. Volume Today’s last reported volume for NASDAQ Composite is 1093603000, 81.35% below its average volume of 5866695185.11. About NASDAQ Composite’s yearly highs and lows, it’s 45.6% up from…

Read More

Riot Blockchain Stock Impressive Jump Before The Weekend, Outperforms Market

(VIANEWS) – The NASDAQ ended the session with Riot Blockchain (RIOT) rising 11.23% to $14.52 on Friday while NASDAQ jumped 1.25% to $15,990.66. Riot Blockchain’s last close was $13.05, 36.8% below its 52-week high of $20.65. About Riot Blockchain Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America….

Read More

Inovio Pharmaceuticals Stock Impressive Rise Before The Weekend, Outperforms Market

(VIANEWS) – The NASDAQ ended the session with Inovio Pharmaceuticals rising 15.85% to $6.65 on Friday, following the last session’s upward trend. NASDAQ jumped 1.25% to $15,990.66, after three consecutive sessions in a row of gains, on what was an all-around bullish trend exchanging session today. Inovio Pharmaceuticals’s last close was $5.74, 75.09% under its…

Read More

FibroGen Stock Was Up By 14.69% Before The Weekend

(VIANEWS) – The NASDAQ ended the session with FibroGen (FGEN) rising 14.69% to $2.73 on Friday while NASDAQ jumped 1.25% to $15,990.66. FibroGen’s last close was $2.38, 90.73% under its 52-week high of $25.68. About FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product…

Read More